ADCT Stock Summary and Trading Ideas (Adc Therapeutics SA Common Shares | NYSE:ADCT)

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Adc Therapeutics SA Common Shares trades on the NYSE stock market under the symbol ADCT.

As of January 23, 2026, ADCT stock price declined to $3.61 with 720,832 million shares trading.

ADCT has a beta of 1.76, meaning it tends to be more sensitive to market movements. ADCT has a correlation of 0.11 to the broad based SPY ETF.

ADCT has a market cap of $447.20 million. This is considered a Small Cap stock.

Last quarter Adc Therapeutics SA Common Shares reported $16 million in Revenue and -$.19 earnings per share. This fell short of revenue expectation by $-89,202 and exceeded earnings estimates by $.19.

In the last 3 years, ADCT traded as high as $6.04 and as low as $.36.

The top ETF exchange traded funds that ADCT belongs to (by Net Assets): IWM, IBB, IWO, VTWO, VFMO.

ADCT has outperformed the market in the last year with a return of +105.1%, while the SPY ETF gained +14.2%. However, in the most recent history, ADCT shares have underperformed the stock market with its stock returning -11.3% in the last 3 month period and -1.4% for the last 2 week period, while SPY has returned +2.9% and -0.7%, respectively.

ADCT support price is $3.67 and resistance is $3.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADCT shares will trade within this expected range on the day.